Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armelle Luscan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Plos One|May 12, 2016
Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept StudyLaïla Allach El Khattabi, Christelle Rouillac-Le Sciellour, Dominique Le Tessier, et al.
BMC Genomics|July 16, 2013
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesisJulien Masliah-Planchon, Eric Pasmant, Armelle Luscan, et al.
Nature|August 15, 2014
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesThomas De Raedt, Eline Beert, Eric Pasmant, et al.
Nature Communications|April 24, 2024
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibitionPierre Romero, Laia Richart, Setareh Aflaki, et al.
Journal of Clinical Medicine|August 6, 2020
Strategy for Use of Genome-Wide Non-Invasive Prenatal Testing for Rare Autosomal Aneuploidies and Unbalanced Structural Chromosomal AnomaliesPascale Kleinfinger, Laurence Lohmann, Armelle Luscan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancerMichel Wassef, Armelle Luscan, Setareh Aflaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesisArmelle Luscan, Ghjuvan'ghjacumu Shackleford, Julien Masliah-Planchon, et al.
Cancer Medicine|June 15, 2019
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomasCamille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, et al.
Journal of Medical Genetics|June 19, 2016
<i>SETD2</i> and <i>DNMT3A</i> screen in the Sotos-like syndrome French cohortCamille Tlemsani, Armelle Luscan, Nicolas Leulliot, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Plos One|May 12, 2016
Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept StudyLaïla Allach El Khattabi, Christelle Rouillac-Le Sciellour, Dominique Le Tessier, et al.
BMC Genomics|July 16, 2013
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesisJulien Masliah-Planchon, Eric Pasmant, Armelle Luscan, et al.
Nature|August 15, 2014
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesThomas De Raedt, Eline Beert, Eric Pasmant, et al.
Nature Communications|April 24, 2024
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibitionPierre Romero, Laia Richart, Setareh Aflaki, et al.
Journal of Clinical Medicine|August 6, 2020
Strategy for Use of Genome-Wide Non-Invasive Prenatal Testing for Rare Autosomal Aneuploidies and Unbalanced Structural Chromosomal AnomaliesPascale Kleinfinger, Laurence Lohmann, Armelle Luscan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancerMichel Wassef, Armelle Luscan, Setareh Aflaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesisArmelle Luscan, Ghjuvan'ghjacumu Shackleford, Julien Masliah-Planchon, et al.
Cancer Medicine|June 15, 2019
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomasCamille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, et al.
Journal of Medical Genetics|June 19, 2016
<i>SETD2</i> and <i>DNMT3A</i> screen in the Sotos-like syndrome French cohortCamille Tlemsani, Armelle Luscan, Nicolas Leulliot, et al.
Pageof 3